Vittia secures R$153 Million as Brazil’s biologicals market enters new phase
Brazilian biologicals company Vittia has secured up to R$153 million ($26.8 million) in financing from Finep, Brazil’s i…
Philippines prepares P45 Billion El Niño response as food prices accelerate
The Philippines is stepping up efforts to protect food supplies and contain prices as a combination of weather disruptio…
China’s new oilseed rape variety delivers record yield in high-altitude trial
A new spring oilseed rape variety developed by the Oil Crops Research Institute of the Chinese Academy of Agricultural S…
Vylor completes Spin, launches as standalone, advanced seed and genetics market leader
Vylor has begun trading as an independent, publicly listed seed and genetics company, completing its separation from Cor…
巴斯夫将推出全新作用机理杀菌剂产品
大豆是世界上重要的经济作物,是食品、饲料、能源的重要资源。巴西、巴拉圭、玻利维亚3国的农民生产了全球44%的大豆,然而,他们却面临着亚洲大豆锈病的严峻挑战。这种难治病害严重…
这一化工园区新片区认定,另一化工园区将扩区
9月,山东化工园区扩区调区再落两子。9月22日,山东省人民政府批复,同意东营港化工产业园南部片区认定,面积5.9981平方千米,要求打造工业经济高质量发展的示范区和引领区。此前一日,滨州滨城化工产业园扩区情况公示,扩区后总…
新科迪华:聚焦植保与生物制剂核心赛道
9月24日,中国农民丰收节后的第一天,距离科迪华按计划于10月1日完成拆分仅剩一周。深耕植保行业10余年的科迪华东亚区总裁郑子勤接受了多家媒体的联合采访。在采访中,郑子勤从…
ADC Therapeutics buys time for Zynlonta with $86.6M financing
The Lausanne-based company plans to use the financing to support further development of its lymphoma drug Zynlonta, including Phase 3 studies combining it with glofitamab in diffuse large B-cell lymphoma and testing it alone in marginal zone lymphoma.
Another bad day at Zealand: Roche-partnered drug disappoints on blood sugar
Why it matters: Zealand and Roche are betting that petrelintide’s tolerability can distinguish it in the crowded obesity market. The latest results strengthen that argument, but raise questions about its competitiveness as a standalone treatment for people who also have type 2 diabetes.
